Home
|
Department News |
Andrew Carlson is UCR's recipient of the American Chemical Society Division of Organic Chemistry's Undergraduate Award in Organic Chemistry for 2013. The award is intended to recognize senior students who display a significant aptitude for organic chemistry and to encourage further interest in the field. Andrew is completing his research on novel luciferins in the laboratory of Prof. Michael Pirrung and will be enrolling in graduate school at UCLA in the Fall. Read More  |
The atom-sized world of carbon nanotubes holds great promise for a future demanding smaller and faster electronic components. Nanotubes are stronger than steel and smaller than any element of silicon-based electronics-the ubiquitous component of today's electrical devices-and have better conductivity, which means they can potentially process information faster while using less energy. The challenge has been figuring out how to incorporate all those great properties into useful electronic devices. A new discovery by four scientists at the University of California, Riverside has brought us closer to the goal. They discovered that by adding ionic liquid-a kind of liquid salt-they can modify the optical transparency of single-walled carbon nanotube films in a controlled pattern. Read More |
Anticancer drugs save lives and/or improve the quality of life for many cancer patients. Many anti-cancer drugs work by killing tumor cells after inducing damage to DNA. The public has an opportunity to learn about the mechanisms of action of some commonly used anticancer drugs and how laboratory research may lead to novel targets and new strategies for cancer treatment. Yinsheng Wang, a professor of chemistry at the University of California, Riverside, will give a free lecture on May 16 on campus to discuss those drugs that induce damage to DNA, as well as those biomolecules that allow for selective targeting of tumor cells. He will also discuss the implications of personalized medicine in cancer treatment. Read More |
American Chemical Society Division of Organic Chemistry's Undergraduate Award
UC Riverside Scientists Discovering New Uses for Tiny Carbon Nanotubes
How Do Anticancer Drugs Work? Public lecture on May 16 at UCR|
Alumni News |
Grace received a Ph.D. in Analytical Chemistry from UCR in 2006 under the mentorship of Prof. Yinsheng Wang. Her thesis was on nucleosomal protein study using mass spectrometry and biochemical techniques. Dr. Grace Jiang joined Amgen in 2006 as a Scientist in Process and Product Development. Amgen is a leading biotechnology company dedicated to deliver innovative and effective therapeutics for patients with serious illness such as cancer, kidney disease, rheumatoid arthritis, bone disease. Read More |
Dr. Susan Srivatsa is the Founder and President of ElixinPharma, a pharmaceutical regulatory consulting firm that provides scientific and technical leadership in the area of Chemistry, Manufacturing and Controls (CMC) for a number of leading companies in various stages of clinical development. The firm specializes in supporting the development of novel technologies such as DNA and RNA therapeutics for which FDA regulatory guidance is currently unavailable. Read More |
Dr. Xinzhao Grace Jiang
Dr. G. Susan Srivatsa